儿童非恶性血液病脾切除术长期随访显示不良反应轻微
该研究回顾性分析了1977至2015年间以色列一家三级中心103例因非恶性血液病行脾切除术的患儿,共1657随访年。未发现典型OPSI病例,血栓事件罕见,但伴中心静脉导管的海洋性贫血患者感染和血栓风险较高。规范术前疫苗接种和随访下,儿童脾切除术相对安全。
要点
- 儿童非恶性血液病脾切除术总体感染和血栓并发症少见
- 伴中心静脉导管的海洋性贫血患者感染和血栓风险最高
- 应避免不必要的中心静脉导管使用以降低风险
核心结论
- 在规范术前疫苗接种和随访下,儿童非恶性血液病脾切除术是相对安全的治疗选择。
- 伴中心静脉导管的海洋性贫血患者感染和血栓风险增加,应尽量避免使用。
研究设计与样本
- 回顾性队列研究,纳入1977至2015年以色列一家三级中心因治疗目的行脾切除术的103例儿童血液病患者,共1657随访年。
主要发现
- 队列包括33例输血依赖型海洋性贫血、7例非输血依赖型海洋性贫血、4例镰状海洋性贫血、41例遗传性球形红细胞增多症和18例免疫性血小板减少症患者。
- 未发现典型的重度脾切除后感染(OPSI)病例,也未分离出典型OPSI细菌。
- 伴中心静脉导管的海洋性贫血患者最易发生感染和血栓形成;除此之外,血栓事件罕见。
临床怎么用
- 儿童非恶性血液病行脾切除术前后应确保规范疫苗接种和随访。
- 海洋性贫血患者应尽可能避免使用中心静脉导管以降低感染和血栓风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Splenectomy is considered therapeutic in various non-malignant haematologic diseases. Adverse events - specifically infections and thromboembolism - are not extensively documented in the paediatric population, maintaining the concern over risks-versus-benefits of the procedure. We studied a cohort of paediatric haematology patients undergoing splenectomy between 1977 and 2015 to determine short- and long-term complications. We summarised all the patients of the haematology clinic in our major Israeli tertiary centre undergoing splenectomy for therapeutic reasons, capturing infectious and thromboembolic events. The data of 103 patients, comprising 1657 follow-up years, were analysed. The cohort included 33 patients with transfusion-dependent thalassaemia, seven with non-transfusion-dependent thalassaemia, four with sickle-thalassaemia, 41 with hereditary spherocytosis, and 18 with immune thrombocytopenia. Standard presplenectomy vaccinations were noted in most. No typical cases of overwhelming postsplenectomy infection (OPSI) were identified, nor were typical OPSI bacteria isolated. Thalassaemics with central lines were most prone to infection and thrombosis. Beyond this subgroup, thrombotic events were anecdotal. This is the largest study to date to comprehensively analyse infectious and thrombotic complications of childhood splenectomy for the treatment of haematologic diseases. The use of splenectomy appears to be a relatively safe therapeutic option in paediatric patients with proper preoperative vaccination and follow-up care; use of central venous lines or catheters increase the risk in thalassaemic patients and should be avoided if possible.
引用
- Yacobovich J, Barzilai-Birenboim S, Steinberg-Shemer O, et al. Splenectomy in childhood for non-malignant haematologic disorders - long-term follow-up shows minimal adverse effects. Br J Haematol. 2020. PMID: 32342506. doi:10.1111/bjh.16657
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。